CRISTIAN Ruiz Rueda

Has grant

Full Professor

California State University Northridge
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Cristian Ruiz Rueda is an Associate Professor at California State University Northridge, USA. His research focuses on the mechanisms of antibiotic resistance, particularly in relation to carbapenem-resistant bacteria in freshwater and marine environments, as well as multidrug efflux pumps in Escherichia coli. Recent publications highlight significant findings in the fields of microbiology and environmental health.

Recent Grants

Grant: Open

RUI: Co-regulation of multidrug efflux and bacterial metabolism

Open Date: 2024-07-15

Close Date: 2028-06-30

Grant: Close

RUI: Unraveling the physiological roles of multidrug efflux pumps in bacteria

Open Date: 2020-07-15

Close Date: 2023-06-30

Grant: Close

Role of multiple antibiotic efflux pumps in the removal of cellular metabolites

Open Date:

Close Date:

Articles (9)

Carbapenems are last-resort antibiotics used to treat multidrug-resistant bacterial infections. Resistance to carbapenems has been designated as an urgent threat and is increasing in healthcare settings. However, little is still known about the distribution and characteristics of carbapenem-resistant bacteria (CRB) outside of healthcare settings. Here, we surveyed the distribution of CRB in ten diverse freshwater and seawater environments in California, U.S., ranging from San Luis Obispo County to San Bernardino County, combining both direct isolation and enrichment approaches to increase the diversity of isolated CRB. From the locations surveyed, we selected 30 CRB for further characterization. These isolates were identified as members of the genera Aeromonas, Enterobacter, Enterococcus, Paenibacillus, Pseudomonas, Sphingobacterium, and Stenotrophomonas. These isolates were resistant to carbapenems, other β-lactams, and often to other antibiotics (tetracycline, gentamicin, or ciprofloxacin). We also found that nine isolates belonging to the genera Aeromonas, Enterobacter (blaIMI-2), and Stenotrophomonas (blaL1) produced carbapenemases. Overall, our findings indicate that sampling different types of aquatic environments and combining different isolation approaches increase the diversity of the environmental CRB obtained. Moreover, our study supports the increasingly recognized role of natural water systems as an underappreciated reservoir of bacteria resistant to carbapenems and other antibiotics, including bacteria carrying carbapenemase genes.

Year:

2024

Year:

2024

Enterobacteriaceae possess eight TolC‐dependent multidrug efflux pumps: AcrAB‐TolC, AcrAD‐TolC, AcrEF‐TolC, MdtEF‐TolC, MdtABC‐TolC, EmrAB‐TolC, EmrYK‐TolC, and MacAB‐TolC, which efflux bile salts, antibiotics, metabolites, or other compounds. However, our understanding of their physiological roles remains limited, especially for less‐studied pumps like EmrYK‐TolC. In this study, we tested the effects on swimming motility and growth under stress conditions of Escherichia coli mutants individually deleted for each inner‐membrane transporter component of all eight TolC‐dependent pumps, a mutant deleted for the AcrB‐accessory protein AcrZ, and a mutant simultaneously deleted for all eight pumps (Δ tolC ). We found that all mutants tested, except the Δ emrY and Δ acrZ mutants, displayed increased swimming motility. Additionally, the loss of each individual TolC‐dependent pump or AcrZ did not reduce growth and sometimes even enhanced it compared to the parental strain under various growth conditions: temperature (LB at 25, 30, 37, and 42°C), pH (LB at pH 6.0, 7.4, and 9.0; and LB buffered to pH 6.0, 7.4, and 8.25), LB with limited air exchange, and nutritional stress (M9‐glucose or M9‐glycerol). In contrast, the Δ tolC mutant grew significantly slower than the parental strain under all conditions tested except in LB‐TRIS pH 7.4 and LB with limited air exchange. Overall, these findings indicate that while individual TolC‐dependent pumps are generally dispensable for growth under many stress conditions in the absence of antimicrobials, possibly due to their partially overlapping substrate profiles, TolC‐dependent efflux is required for maximal growth under most conditions.

Year:

2024

Aims Cupriavidus isolates are found in environmental and clinical samples and are often resistant to carbapenems, which are last-resort antibiotics. However, their carbapenem-resistance molecular mechanisms remain unknown. This study aimed to (i) characterize and sequence the carbapenem-resistant soil isolate Cupriavidus taiwanensis S2-1-W to uncover its antibiotic resistance determinants; and (ii) clone and characterize a putative novel carbapenemase gene identified in this isolate. Methods and results Antibiotic susceptibility testing of C. taiwanensis S2-1-W revealed that it was resistant to most carbapenems, other β-lactams, and aminoglycosides tested. Genome sequencing of this isolate revealed a complex chromosomal resistome that included multidrug efflux pump genes, one aminoglycoside transferase gene, and three β-lactamase genes. Among them, we identified a novel putative class D β-lactamase gene (blaOXA-1206) that is highly conserved among other sequenced C. taiwanensis isolates. Cloning and characterization of blaOXA-1206 confirmed that it encodes for a newly discovered carbapenemase (OXA-1206) that confers resistance to carbapenems and other β-lactams. Conclusion Carbapenem-resistance in C. taiwanensis S2-1-W is associated with a newly discovered carbapenemase, OXA-1206.

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (2)

Dana Harmon

Lecturer

California State University Northridge

UNITED STATES
View details

Manny Bacolod

Assistant Professor

Weill Cornell Medicine

UNITED STATES
View details